Joerger Andreas C, Ang Hwee Ching, Veprintsev Dmitry B, Blair Caroline M, Fersht Alan R
Centre for Protein Engineering, Medical Research Council, Cambridge, CB2 2QH, United Kingdom.
J Biol Chem. 2005 Apr 22;280(16):16030-7. doi: 10.1074/jbc.M500179200. Epub 2005 Feb 9.
We have solved the crystal structures of three oncogenic mutants of the core domain of the human tumor suppressor p53. The mutations were introduced into a stabilized variant. The cancer hot spot mutation R273H simply removes an arginine involved in DNA binding without causing structural distortions in neighboring residues. In contrast, the "structural" oncogenic mutations H168R and R249S induce substantial structural perturbation around the mutation site in the L2 and L3 loops, respectively. H168R is a specific intragenic suppressor mutation for R249S. When both cancer mutations are combined in the same molecule, Arg(168) mimics the role of Arg(249) in wild type, and the wild type conformation is largely restored in both loops. Our structural and biophysical data provide compelling evidence for the mechanism of rescue of mutant p53 by intragenic suppressor mutations and reveal features by which proteins can adapt to deleterious mutations.
我们解析了人类肿瘤抑制因子p53核心结构域的三种致癌突变体的晶体结构。这些突变被引入到一个稳定的变体中。癌症热点突变R273H只是去除了一个参与DNA结合的精氨酸,而不会导致相邻残基的结构扭曲。相比之下,“结构性”致癌突变H168R和R249S分别在L2和L3环的突变位点周围诱导了实质性的结构扰动。H168R是R249S的一个特定基因内抑制突变。当这两种癌症突变在同一分子中同时存在时,精氨酸168模仿了野生型中精氨酸249的作用,并且在两个环中野生型构象在很大程度上得以恢复。我们的结构和生物物理数据为基因内抑制突变拯救突变型p53的机制提供了令人信服的证据,并揭示了蛋白质能够适应有害突变的特征。